Immune-based therapies: A review of clinical endpoints used in trials of selected immunologic agents, by the Forum for Collaborative HIV Research
- 2 February 2002
- journal article
- review article
- Published by Taylor & Francis in HIV Research & Clinical Practice
- Vol. 3 (1) , 58-88
- https://doi.org/10.1310/ft44-2d7q-ujfd-r6ry
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppressionAIDS, 2000
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- BasiliximabDrugs, 1999
- Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipientsThe Lancet, 1997
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritisArthritis & Rheumatism, 1995
- Measurement of health status in children with juvenile rheumatoid arthritisArthritis & Rheumatism, 1994
- Increased Concentrations of Soluble Tumor Necrosis Factor Receptor 75 but Not of Soluble Intercellular Adhesion Molecule-1 Are Associated with the Decline of CD4+ Lymphocytes in HIV InfectionClinical Immunology and Immunopathology, 1994
- The health assessment questionnaire 1992. Status and reviewArthritis & Rheumatism, 1992
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981